Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing me

Verve TherapeuticsMay 3 12:00

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS

BenzingaApr 24 04:31

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages...

Stockhouse Apr 21 23:00

Wolf Haldenstein Adler Freeman & Herz LLP Announces That It Is Investigating Verve Therapeutics, Inc. for Potential Violations of Federal Securities Laws

NEW YORK, April 19, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating c

PR NewswireApr 19 22:30

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go

BenzingaApr 11 20:46

Buy Rating on Verve Therapeutics: Promising Gene Editing Prospects and Anticipated Recovery

TipRanksApr 8 18:25